Top Page
NOVONIX Ltd Sponsored ADR
(NASDAQ:NVX)
NOVONIX Ltd Sponsored ADR (NVX) vs. SPDR S&P 500 ETF (SPY)
NOVONIX Ltd Sponsored ADR Business Overview & Revenue Model
NOVONIX Ltd Sponsored ADR Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.84M | 8.42M | 5.85M | 12.13M | ― | 6.10M |
| Gross Profit | -9.49M | -36.50M | 4.08M | 9.32M | -20.63M | 4.38M |
| EBITDA | -66.41M | -115.59M | -66.61M | -38.86M | -33.28M | -43.26M |
| Net Income | -74.63M | -139.06M | -74.82M | -46.25M | -38.08M | -51.86M |
Balance Sheet | ||||||
| Total Assets | 226.10M | 423.84M | 226.10M | 263.34M | 189.59M | 302.98M |
| Cash, Cash Equivalents and Short-Term Investments | 42.56M | 126.06M | 42.56M | 78.63M | 73.93M | 142.74M |
| Total Debt | 70.42M | 165.94M | 70.42M | 68.22M | 31.34M | 41.41M |
| Total Liabilities | 88.51M | 188.42M | 88.51M | 83.74M | 38.20M | 51.85M |
| Stockholders Equity | 137.59M | 235.42M | 137.59M | 183.94M | 151.39M | 251.13M |
Cash Flow | ||||||
| Free Cash Flow | -55.32M | -153.52M | -70.32M | -55.42M | -29.65M | -113.02M |
| Operating Cash Flow | -40.26M | -63.29M | -40.42M | -36.23M | -12.89M | -29.23M |
| Investing Cash Flow | -22.97M | -49.28M | -18.17M | -12.04M | -16.10M | -106.80M |
| Financing Cash Flow | 24.64M | 164.81M | 25.21M | 44.16M | -531.57K | 180.69M |
NOVONIX Ltd Sponsored ADR Technical Analysis
NOVONIX Ltd Sponsored ADR Risk Analysis
NOVONIX Ltd Sponsored ADR Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | $1.10B | -10.09 | -0.23% | ― | 45.98% | 44.14% | |
51 Neutral | $23.79M | -1.45 | 209.00% | ― | ― | 61.78% | |
50 Neutral | $3.35B | -1.40 | -110.00% | ― | 2.53% | -2.83% | |
48 Neutral | $357.60M | -4.17 | -26.54% | ― | 41.05% | -1.02% | |
45 Neutral | $34.24M | -0.43 | -265.36% | ― | -3.53% | 24.37% | |
42 Neutral | $149.50M | -1.85 | -75.11% | ― | -14.27% | -28.56% |
NOVONIX Ltd Sponsored ADR Corporate Events
Novonix Limited has called its 2026 Annual General Meeting for 15 April 2026 at 9 a.m. Brisbane time, to be held as a hybrid event with both online and in‑person participation in Brisbane. Shareholders will receive the FY25 financial statements and reports and will be able to watch, ask questions and vote via a virtual platform or at the physical venue, underlining the company’s continued use of flexible governance arrangements.
The AGM agenda includes an advisory vote on the 2025 remuneration report, the re-election of directors Admiral Robert J. Natter and Ronald Edmonds, and a raft of equity-related resolutions. These cover approval of the company’s Performance Rights Plan, new FY26 performance rights for CEO Michael O’Kronley, and FY26 share rights issuances to key strategic partner Phillips 66 and several non-executive directors, signaling an ongoing emphasis on equity-based incentives and alignment with management, board and partners.
The most recent analyst rating on (NVX) stock is a Hold with a $0.76 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
On March 13, 2026, NOVONIX Limited reported that the U.S. International Trade Commission concluded Chinese imports of anode active material do not materially impede the U.S. graphite industry, blocking new anti-dumping and countervailing duties despite prior findings by the U.S. Department of Commerce. The company said it was disappointed but highlighted that existing Section 301 tariffs and a new temporary global import duty keep total tariffs at 35%, while NOVONIX continues to advance U.S. synthetic graphite production underpinned by binding offtake agreements with Panasonic Energy and PowerCo, reinforcing its role in domestic battery supply chains and access to U.S. production tax credits.
NOVONIX stressed that its advanced synthetic graphite capabilities position it to benefit from customers seeking secure, non-Chinese anode materials to qualify for 45X production tax credits. The company said its ongoing expansion of U.S. manufacturing supports supply chain resilience, U.S. energy security and long-term competitiveness, partly offsetting the setback from the ITC decision for domestic producers and stakeholders invested in localizing battery materials production.
The most recent analyst rating on (NVX) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
On March 13, 2026, Novonix Ltd reported the issue of 5,517,712 unquoted performance rights under its employee incentive scheme, designated under the ASX security code NVXAD. The new performance rights, which rank equally with existing rights in that class and did not require shareholder approval under Listing Rule 7.2 exception 13, increase the total NVXAD performance rights on issue to 28,735,426 and include sizeable allocations to key executives.
The March 13 issuance granted 2,069,142 performance rights to Chief Executive Officer Robert Long and 1,724,285 rights each to executives Kimberly Heimert and Dwayne Johnson, reinforcing equity-based compensation for senior management. Following this transaction, Novonix’s capital structure comprises 861,365,155 quoted ordinary shares and a significant suite of unquoted instruments, underlining the company’s ongoing use of equity incentives to align leadership and employee interests with long-term shareholder value.
The most recent analyst rating on (NVX) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
On March 12, 2026, Novonix Limited filed a Form 6-K with the U.S. Securities and Exchange Commission, notifying investors of a change in a director’s shareholding as required for foreign private issuers. The filing included an Appendix 3Y lodged with the ASX detailing that director Nicholas Liveris conducted an on‑market sale of 30,052 ordinary shares on March 10, 2026, for consideration of $9,194, reducing his direct holding from 589,142 to 559,090 shares, and confirming that the trade did not occur during a closed period, thereby signaling routine governance-driven disclosure rather than a structural shift in company strategy or control.
The most recent analyst rating on (NVX) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
On March 11, 2026, Novonix Limited filed a Form 6-K in the United States and an Appendix 2A with the ASX documenting the quotation of 451,991 new ordinary fully paid shares under ticker NVX. These shares were issued at an estimated value of A$0.30 per share upon the vesting and conversion of employee performance rights, with the underlying options first exercised on March 11, 2026 and ranking equally with existing stock.
The move modestly increases Novonix’s free float to 861,365,155 quoted ordinary shares while leaving a substantial pool of 23.2 million performance rights and other convertible instruments outstanding. The transaction underscores the company’s ongoing use of equity-based compensation and convertible securities, which may incrementally dilute existing shareholders over time as additional awards vest and convert into listed stock.
The most recent analyst rating on (NVX) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
Novonix Limited, listed on the ASX under ticker NVX, reported updated capital information following the conversion of performance rights into ordinary fully paid shares on March 3, 2026. Following this issuance, the company’s quoted share capital rose to 860,913,164 ordinary shares, while a substantial pool of unquoted performance rights, options, convertible notes and debentures remains outstanding.
In a filing dated March 3, 2026, Novonix applied for quotation of 2,177 additional ordinary shares that were issued at an implied value of A$0.335 each upon vesting of employee performance rights. The move reflects ongoing use of equity-based incentives, creating limited dilution for existing shareholders but signaling continued reliance on share-based compensation in the company’s broader capital management strategy.
The most recent analyst rating on (NVX) stock is a Hold with a $0.93 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
NOVONIX Limited, a battery materials and technology specialist, aims to reduce supply chain risk and support U.S. energy independence by developing an integrated North American supply chain for advanced battery materials. Its operations span anode materials manufacturing, innovative cathode technologies and battery testing services, positioning the company as a key supplier to the energy storage and electrification economy.
On February 18, 2026, NOVONIX announced that its 2026 Annual General Meeting will be held in Brisbane on April 15, 2026, at 9:00 a.m. AEST. The company also set February 25, 2026, at 5:00 p.m. AEST as the deadline for shareholders to submit nominations for directors, a step that frames the timeline for potential changes or confirmations in board composition ahead of the AGM.
The most recent analyst rating on (NVX) stock is a Hold with a $0.90 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
On 18 February 2026, NOVONIX Limited announced it has entered into a binding term sheet to sell its NOVONIX Battery Technology Solutions Inc. business in Nova Scotia, Canada, to former chief executive Chris Burns, in a share sale that transfers all related assets and liabilities for a nominal US$1.00. The deal, which includes a 15% non‑dilutable equity stake for NOVONIX in the buyer’s cathode business and transitional support through at least September 2026, continues the company’s exit from non-core assets after its September 2025 sale of the Mt. Dromedary natural graphite project and sharpens its strategic focus on a vertically integrated synthetic graphite supply chain in North America, with implications for capital allocation, management attention and its positioning in critical battery materials markets.
The most recent analyst rating on (NVX) stock is a Hold with a $0.90 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.
On February 13, 2026, NOVONIX Limited said it welcomed final U.S. Department of Commerce determinations that set combined antidumping and countervailing duties of at least 160% on Chinese battery-grade anode active materials, pending a final U.S. International Trade Commission ruling expected in March. The tariffs, which cover both synthetic and natural graphite products and are reviewed every five years, sit on top of existing 25% Section 301 and 20% IEEPA tariffs and are intended to counter trade distortions in the U.S. anode materials market.
NOVONIX’s CEO said the measures should help restore fair competition, spur domestic investment in critical battery materials, and support advanced manufacturing jobs, effectively improving the company’s competitive position as it scales synthetic graphite production in North America. With what it describes as the most advanced synthetic graphite capability in the region and an expanding U.S. production footprint, NOVONIX positions itself as a key beneficiary of the new trade regime and a strategic supplier for customers seeking secure, domestically produced anode materials.
The most recent analyst rating on (NVX) stock is a Hold with a $0.90 price target. To see the full list of analyst forecasts on NOVONIX Ltd Sponsored ADR stock, see the NVX Stock Forecast page.